On September 19, 2012 (found here), we recommended that investors consider selling Abbott Labs (ABT), at least the principal portion. At the time, ABT was trading at a split-adjusted $33. by October 16, 2012, shortly after our sell recommendation, Abbott rose as high as $34.67 or +5.06%.
-
Topics
Archives
-
-
Recent Posts
-
-
-
-